Dr. Gregory P. Kalemkerian, Co-Director of Thoracic Oncology

Gregory P. Kalemkerian

Co-Director of Thoracic Oncology

Dr. Gregory P. Kalemkerian has dedicated his time to researching effective treatments for lung cancer and mesothelioma. Throughout his career as a medical oncologist, he has acted as an unparalleled resource for his patients.

Get in touch

About Gregory P. Kalemkerian

  • Pleural and Lung Cancer icon

    Pleural and Lung Cancer

  • Research Excellence icon

    Excellence in Research

  • Top Doctor icon

    Top Doctor

  • Board Certified icon

    Board Certified in Medical Oncology

  • Board Certified icon

    Board Certified in Internal Medicine

In 2002, Dr. Gregory Kalemkerian collaborated with doctors from 18 other leading cancer centers to release “Lung Cancer Treatment Guidelines for Patients,” a booklet to aid cancer patients in making treatment decisions.

“This is really a step-by-step guide that takes patients through the general concepts of their care from diagnosis to treatment,” explained Kalemkerian, the co-director of thoracic oncology at University of Michigan’s Comprehensive Cancer Center.

Focus on Lung Cancer

He also compiled a list of the top nine facts about lung cancer. The list stresses the importance – and difficulty – of an early diagnosis for any lung-related illness.

Dr. Kalemkerian Co-Director of Thoracic Oncology

“Surgery is the most curable treatment for almost any cancer but few people with lung cancer come in early enough for us to do this.”

He explained that this is largely because of current testing procedures.

“We have yet to identify a screening test that has impacted mortality rates,” he said. “But we are working on it.”

In addition to acting as a leading source of information and research in the field of thoracic oncology, Kalemkerian also works to increase awareness of the prevalence of lung cancer and related illnesses.

Talk to a Doctor About Your Diagnosis

We can help you or a loved one get in contact with Dr. Kalemkerian and find the treatment that's best for you.

Get Started Today

“If you add up the number of people in the United States who die of breast cancer, prostate cancer, colon cancer and pancreatic cancer, the number of people who die of lung cancer is greater than all of those combined,” he said.

Kalemkerian has authored more than 50 publications about thoracic oncology, mesothelioma and related topics. He is also a professor in University of Michigan’s Department of Internal Medicine.

Quick Fact:

Dr. Kalemkerian serves on three medical teams at the University of Michigan – Hematology/Oncology; Multidisciplinary Team for Lung Cancer and the Medical and Surgical Oncology Team Two.


As the contributing author for 44 articles discussing lung cancer, doctor ethics, chemotherapy and CT-scans, Kalemkerian has been published in leading scientific journals such as the Journal of Thoracic Oncology and the Journal of Palliative Medicine. In 2008, he worked as one of 13 medical professionals to write “Pemetrexed plus Gemcitabine as First-Line Chemotherapy for Patients with Peritoneal Mesothelioma” after a phase II clinical trial.

Disclaimer: Dr. Gregory P. Kalemkerian has no professional affiliation with Asbestos.com.

stethoscope icon
Get Help Contacting this Doctor

We value your privacy. By submitting, you agree to our privacy policy and disclaimer.

Get the Best Treatment Options

Find a Doctor
Asbestos.com Mesothelioma Packet

Order Your Free Treatment Guide

Get Yours Now

Find a Mesothelioma Clinical Trial Near You

Get Help Now

Senior Content Writer

Tim Povtak is an award-winning writer with more than 30 years of reporting national and international news. His specialty is interviewing top mesothelioma specialists and researchers, reporting the latest news at mesothelioma cancer centers and talking with survivors and caregivers.

Walter Pacheco, Managing Editor at Asbestos.com
Edited by

4 Cited Article Sources


Did this article help you?

Did this article help you?

Thank you for your feedback. Would you like to speak with a Patient Advocate?

On This Page

Back to Top

Share this article

Last Modified November 16, 2018

Get Your Free Mesothelioma Guide Chat live with a patient advocate now